US Broker Ratings

Mind Medicine Inc. (MNMD) Investor Outlook: A Biotech Stock with a Promising 237% Upside Potential

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), a pioneering entity in the biotechnology sector, is capturing the attention of investors due to its significant growth potential. With..

Cel-Sci Corporation (CVM): Investor Outlook Reveals Astonishing 10,070% Potential Upside

For investors keen on the biotechnology sector, Cel-Sci Corporation (CVM) presents a particularly intriguing opportunity. Despite a current market cap of just $12.12 million and a..

Castle Biosciences, Inc. (CSTL) Stock Analysis: Exploring a 125% Potential Upside in the Molecular Diagnostics Arena

Castle Biosciences, Inc. (NASDAQ: CSTL) has captured investor attention with its compelling growth potential in the specialized field of molecular diagnostics. Operating within the healthcare sector,..

ATAI Life Sciences N.V. (ATAI) Stock Analysis: A Look at the 244.83% Potential Upside in the Biotech Sector

ATAI Life Sciences N.V. (NASDAQ: ATAI), a burgeoning player in the biotechnology sector, presents a compelling opportunity for investors with its focus on mental health treatments...

Sionna Therapeutics, Inc. (SION) Stock Analysis: A Promising 172.86% Upside Potential in Biotech

Sionna Therapeutics, Inc. (SION), a burgeoning entity within the biotechnology sector, is capturing investor attention with an enticing potential upside of 172.86%. As a clinical-stage biopharmaceutical..

Butterfly Network, Inc. (BFLY) Stock Analysis: A 71% Potential Upside Sparks Investor Interest

Butterfly Network, Inc. (NASDAQ: BFLY), a key player in the medical devices sector, presents a unique investment opportunity with its innovative ultrasound imaging solutions. Headquartered in..

Orthofix Medical Inc. (OFIX)

⚠️ No article content returned.

..

Surmodics, Inc. (SRDX) Investor Outlook: A Healthcare Innovator with 45.61% Potential Upside

Surmodics, Inc. (NASDAQ: SRDX), a pivotal player in the healthcare sector, is drawing investor attention with a robust potential upside of 45.61%. Specializing in medical devices..

Standard BioTools Inc. (LAB) Investor Outlook: Exploring a 124% Upside Potential

Standard BioTools Inc. (NASDAQ: LAB) presents a unique opportunity for investors in the healthcare sector, particularly within the medical devices industry. Despite facing several challenges, the..

Autolus Therapeutics (AUTL) Stock Report: Analyzing the 469% Potential Upside in Biotech

Autolus Therapeutics plc (NASDAQ: AUTL), a UK-based clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with an enticing potential upside of 469.52%. Known for..

Verastem, Inc. (VSTM) Stock Analysis: A Biotech with Over 100% Potential Upside

Verastem, Inc. (NASDAQ: VSTM) is capturing the attention of investors with its significant potential upside in the biotechnology sector. With a market cap of approximately $426.96..

Precigen, Inc. (PGEN) Stock Analysis: Exploring a 341% Potential Upside in the Biotech Sector

Investors with an eye on the biotechnology sector may find Precigen, Inc. (NASDAQ: PGEN) a compelling opportunity given its potential for significant upside. With a market..

Definitive Healthcare Corp. (DH) Stock Analysis: Exploring a 25% Potential Upside in the Health Information Services Sector

Definitive Healthcare Corp. (NASDAQ: DH) stands as a key player in the healthcare sector, providing a comprehensive software-as-a-service (SaaS) platform that delivers valuable commercial intelligence to..

Kura Oncology, Inc. (KURA) Stock Analysis: Exploring a 345% Potential Upside in the Biotech Sector

Kura Oncology, Inc. (NASDAQ: KURA) has emerged as a compelling player in the biotechnology sector, primarily focusing on developing targeted cancer therapies. With a market capitalization..

Embecta Corp. (EMBC): Investor Outlook with a Promising 69.78% Potential Upside

Embecta Corp. (EMBC), a company deeply rooted in the healthcare sector, specializes in medical instruments and supplies. Founded in 1924 and based in Parsippany, New Jersey,..

AbCellera Biologics Inc. (ABCL) Stock Analysis: Exploring a Potential 313% Upside

For investors seeking opportunities in the biotechnology sector, AbCellera Biologics Inc. (NASDAQ: ABCL) presents an intriguing prospect. With a market capitalization of approximately $608.91 million, this..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Report: Navigating Challenges with a 13.10% Upside Potential

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), a pioneering player in the biotechnology sector, has garnered attention for its innovative approach to cell programming. Despite facing some..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Insights into Growth Potential and Market Position

Fulgent Genetics, Inc. (NASDAQ: FLGT), operating within the dynamic healthcare sector of diagnostics and research, presents an intriguing opportunity for investors looking to capitalize on the..

CeriBell, Inc. (CBLL) Stock Analysis: Healthcare Innovator with 82% Upside Potential

CeriBell, Inc. (CBLL), a medical technology company specializing in cutting-edge neurology solutions, is positioned at the intersection of healthcare innovation and investment opportunity. Headquartered in Sunnyvale,..

Tectonic Therapeutic, Inc. (TECX): Unpacking a Promising 269% Upside Potential

In the dynamic landscape of biotechnology, Tectonic Therapeutic, Inc. (NASDAQ: TECX) stands out with its innovative approach to drug discovery and development. This Watertown, Massachusetts-based company..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds